FRIDAY, Dec. 22, 2023 (HealthDay News) — Online gaming and vaping to the point of addiction have become widespread enough that most high school counselors regularly confront these behaviors in today’s teens, a new survey shows. Four out of five counselors say they’ve worked with at least one student during theContinue Reading
THURSDAY, Dec. 21, 2023 (HealthDay News) — A newly approved test can determine whether a person has a genetically driven risk of becoming addicted to opioids. The AvertD test, the first of its kind, uses a DNA sample swabbed from a patient’s cheek to determine if they have a combinationContinue Reading
WEDNESDAY, Dec. 20, 2023 (HealthDay News) — The new COVID variant known as JN.1 was named a “variant of interest” by the World Health Organization on Tuesday, which means health officials are now closely tracking its rapid spread across the globe. So far, the highly mutated variant has not beenContinue Reading
MONDAY, Dec. 18, 2023 (HealthDay News) — Most parents plan to have their kids vaccinated against influenza and respiratory syncytial virus (RSV), even as COVID-19 vaccine acceptance flags, a new poll finds. Seven in 10 parents (71%) plan to have their children get an RSV jab and six in 10Continue Reading
MONDAY, Dec. 18, 2023 (HealthDay News) — If you’re one of the 50 million Americans with asthma or allergies, 2024 is another year to redouble efforts to manage them. But how? “It’s not always easy to get allergies and asthma under control,” allergist Dr. Gailen Marshall, president of the AmericanContinue Reading
FRIDAY, Dec. 15, 2023 (HealthDay News) — A new melanoma vaccine has shown its mettle in battling the deadly skin cancer in a new trial. People with advanced melanomas who received the vaccine plus Merck’s cancer drug Keytruda were 49% less likely to die or have their cancer return afterContinue Reading
FRIDAY, Dec. 15, 2023 (HealthDay News) — The first postpartum depression pill approved for use in the United States is now available to women who need it, the drug’s makers announced Thursday. Sold under the name Zurzuvae, the medication can quickly ease severe postpartum depression and help women regain theirContinue Reading
FRIDAY, Dec. 15, 2023 (HealthDay News) — Low vaccination rates for the flu, RSV and COVID-19 are putting Americans at higher risk for severe illness and hospitalization this winter, a new government alert warned Thursday. There is an “urgent need” to boost vaccination rates as the trio of viruses spreadContinue Reading
THURSDAY, Dec. 14, 2023 (HealthDay News) — The market for cannabidiol (CBD) and other products derived from the hemp plant is now wide open in the United States, but that could bring danger to consumers, the authors of a new report warn. Many people may not realize it, but there’sContinue Reading
THURSDAY, Dec. 14, 2023 (HealthDay News) — Mpox is making headlines again, as an outbreak of severe disease in the Democratic Republic of Congo in Africa has infected thousands of people and killed hundreds. Amid this worrying scenario, researchers at New York University (NYU) offer a glimmer of good news:Continue Reading
WEDNESDAY, Dec. 13, 2023 (HealthDay News) — While rates of a deadly heart infection are dropping generally across the United States, a new report finds one exception: Young adults. In that group, rates of infective endocarditis are rising, probably fueled by a common cause, injected drug abuse. “Substance use wasContinue Reading
WEDNESDAY, Dec. 13, 2023 (HealthDay News) — Teens who avidly use weed typically use it either for enjoyment or to cope, but both uses have a dark side to them, new research finds. Teenagers who use marijuana for enjoyment or to forget their problems have more demand for it, meaningContinue Reading
MONDAY, Dec. 11, 2023 (HealthDay News) — In response to the ongoing crisis of opioid misuse, U.S. doctors had already cut the amount of opioids they gave patients after surgery by 2022 to just a third of the amount given in 2016, new research shows. Much of the decline happenedContinue Reading
WEDNESDAY, Dec. 6, 2023 (HealthDay News) — The newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday. “Today opens another chapter for adults living with obesity who have been looking for a new treatment option like Zepbound,” Rhonda Pacheco,Continue Reading